[Impact on weight loss and body composition of a food education intervention associated with Liraglutide treatment to address obesity]

What Was Tested

This randomized controlled trial paper looks at Liraglutide in the context of fat loss, obesity & body recomposition.

Objective: to analyze the changes in weight, body mass index and body composition by means of electrical bioimpedance after a 32-week treatment with liraglutide in patients with obesity, associated or not with a food education program.

Why It Was Studied

Materials and methods: the study involved 68 patients who were randomly divided into 2 groups.

The data collected were weight (kg), height (m) (Seca® brand), body mass index (kg/m2) and body composition using multifrequency bioimpedance (SECA 112® brand).

Who Took Part

The abstract describes 68 patients taking part.

PubMed indexes the participants as adults and middle-aged adults, both men and women.

How the Study Was Run

In design terms this was a randomized study.

Random assignment meant chance, not the researchers, decided who got Liraglutide and who got the comparison, which limits bias.

A time span of 32 weeks appears in the methods.

What Was Measured

Topics PubMed links to this paper include Liraglutide, Body Composition, Obesity, Weight Loss, Body Mass Index and Patient Education as Topic.

The authors tagged it with the keywords Obesidad. Composición corporal. Pérdida de peso. Educación alimentaria. Liraglutida..

What This Means in Plain Language

The paper is a randomized study of Liraglutide in 68 patients in people with fat loss, obesity & body recomposition over 32 weeks.

The publication is from 2024 (Nutricion hospitalaria), a journal based in Spain.

More context: the Liraglutide compound page, Fat loss, obesity & body recomposition research.